Evogene Q2 EPS $(0.32) Misses $(0.18) Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 100 percent decrease over losses of $(0.16) per share from the same